Free Trial

BioCryst Pharmaceuticals (BCRX) Insider Trading & Ownership

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)
Free BCRX Stock Alerts
$4.16
0.00 (0.00%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$31,920.00
Get BCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioCryst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCRX Insider Buying and Selling by Quarter

Ad Banyan Hill Publishing
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)
Watch my video for all of the details

BioCryst Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/16/2023Josh GottheimerU.S. Congress Member (D-NJ)Buy$5.94$1,001 - $15,000
9/15/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$6.85$1,001 - $15,000
6/15/2023Machelle SandersDirectorSell4,000$7.98$31,920.00  
(Data available from 1/1/2013 forward)

BCRX Insider Trading Activity - Frequently Asked Questions

Who is on BioCryst Pharmaceuticals's Insider Roster?

The list of insiders at BioCryst Pharmaceuticals includes Anthony Doyle, George B Abercrombie, Helen M Thackray, Jon P Stonehouse, Machelle Sanders, Michael L Jones, Nancy J Hutson, Vincent Milano, William P Sheridan, and Yarlagadda S Babu. Learn more on insiders at BCRX.

What percentage of BioCryst Pharmaceuticals stock is owned by insiders?

4.40% of BioCryst Pharmaceuticals stock is owned by insiders. Learn more on BCRX's insider holdings.

Which BioCryst Pharmaceuticals insiders have been selling company stock?

The following insiders have sold BCRX shares in the last 24 months: Anthony Doyle ($62,130.00), Helen M Thackray ($34,031.25), Jon P Stonehouse ($2,249,686.80), Machelle Sanders ($31,920.00), Michael L Jones ($116,736.50), and Yarlagadda S Babu ($437,428.20).

How much insider selling is happening at BioCryst Pharmaceuticals?

Insiders have sold a total of 250,141 BioCryst Pharmaceuticals shares in the last 24 months for a total of $2,931,932.75 sold.

Which members of congress are trading BioCryst Pharmaceuticals?

Josh Gottheimer (D-NJ) has bought shares of BioCryst Pharmaceuticals in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BCRX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The World's First "$20 Trillion Drug?"
Behind the Markets
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press